Chitose Oneyama Selected Research

Cortactin

5/2006

Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chitose Oneyama Research Topics

Disease

22	Neoplasms (Cancer) 04/2022 - 05/2006
3	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2006
3	Colonic Neoplasms (Colon Cancer) 07/2018 - 10/2010
2	Carcinoma (Carcinomatosis) 01/2015 - 05/2006
1	Pathologic Processes 10/2022
1	Kidney Neoplasms (Kidney Cancer) 04/2022
1	Lymphoma (Lymphomas) 01/2021
1	Triple Negative Breast Neoplasms 10/2020
1	Carcinogenesis 04/2019
1	Lung Neoplasms (Lung Cancer) 09/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017
1	Osteosarcoma (Osteogenic Sarcoma) 01/2012
1	Inflammation (Inflammations) 03/2007
1	Hyperplasia 03/2007
1	Glioblastoma (Glioblastoma Multiforme) 05/2006
1	Breast Neoplasms (Breast Cancer) 05/2006

Drug/Important Bio-Agent (IBA)

10	CSK Tyrosine-Protein KinaseIBA 02/2020 - 03/2007
5	MicroRNAs (MicroRNA)IBA 02/2020 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2011
4	src-Family KinasesIBA 09/2017 - 03/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2022 - 05/2011
2	LuciferasesIBA 04/2022 - 01/2022
2	Sirolimus (Rapamycin)FDA Link 10/2020 - 01/2015
2	PaxillinIBA 07/2018 - 01/2016
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2017 - 10/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2015 - 01/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2022
1	Biological ProductsIBA 10/2022
1	Membrane LipidsIBA 10/2022
1	asteltoxinIBA 01/2022
1	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 01/2022
1	pyrimidineIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Hormones (Hormone)IBA 10/2020
1	Epidermal Growth Factor (EGF)IBA 10/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2019
1	Messenger RNA (mRNA)IBA 07/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	AfatinibIBA 09/2017
1	osimertinibIBA 09/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2017
1	ErbB Receptors (EGF Receptor)IBA 09/2017
1	GTP Phosphohydrolases (GTPases)IBA 04/2016
1	Mevalonic Acid (Mevalonate)IBA 04/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	IntegrinsIBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2015
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2012
1	Matrix Metalloproteinase 13IBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	Mitogen-Activated Protein KinasesIBA 05/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2011
1	Carrier Proteins (Binding Protein)IBA 05/2011
1	6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA 10/2010
1	Growth Factor ReceptorsIBA 10/2010
1	Cyclin D1IBA 01/2008
1	Indicators and Reagents (Reagents)IBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2007
1	Pharmaceutical PreparationsIBA 05/2006
1	Peptides (Polypeptides)IBA 05/2006
1	CortactinIBA 05/2006
1	UCS15AIBA 05/2006
1	Proline (L-Proline)FDA Link 05/2006

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2006
1	Transplantation 10/2020
1	Drug Therapy (Chemotherapy) 04/2016